SWOG clinical trial number
SWOG-8834
A Phase II Evaluation of Fazarabine in Central Nervous System Tumors
Closed
Phase
Accrual
45%
Published
Abbreviated Title
Fazarabine in CNS Tumors
Activated
07/01/1990
Closed
12/01/1991
Research committees
Brain Cancer
Treatment
Fazarabine
Publication Information Expand/Collapse
1994
A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study